Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis?
Gayathri Swaminathan, Yu-Chu Lin, Jianbo Ni, Asna Khalid, Cheng‐Yu Tsai, Ying Ding, Na Bo, Judy‐April Murayi, Thottala Jayaraman, Ronald Poropatich, Rita Bottino, Georgios I. Papachristou, Sunil G. Sheth, Wen Li, Monique T. Barakat, Adam Frymoyer, Mang Yu, Sohail Z. Husain
Topics & Concepts
MedicineDiclofenacPharmacokineticsPancreatitisDosingRectal administrationAcute pancreatitisGastroenterologyAdverse effectPancreasPharmacologyInternal medicineGallbladder and Bile Duct DisordersMedical Device Sterilization and DisinfectionInflammatory mediators and NSAID effects